Insights - Synergy Pharmaceuticals (SGYP) cleared out a major overhang on Wednesday Oct. 28 – evidenced by the stock’s 15% move higher in the session – with the … Continue Reading
Read NowInsights - On Monday morning, Sarepta Therapeutics (SRPT) held a teleconference concerning regulatory updates for Eteplirsen, the company’s lead drug candidate for Duchenne Muscular Dystrophy. In a Type B … Continue Reading
Read NowInsights - Shire PLC (SHPG) reported record third quarter revenues on Friday – $1.6 billion and 33% growth over the year-ago quarter – with earnings of $2.93 per share. The company … Continue Reading
Read NowInsights - Tekmira Pharmaceuticals (TKMR) and European drug developer Bavarian Nordic (BAVA.CO) are receiving significant attention in early trading on Wednesday morning with announcements that their two … Continue Reading
Read NowInsights - Agios Pharmaceuticals (AGIO) announced on Tuesday the initiation of a phase I/II multicenter study of AG-221 in patients with advanced solid tumors that carry an … Continue Reading
Read NowInsights - Synergy Pharmaceuticals (SGYP) is getting some much-needed love with phase 2 data for the company's lead drug candidate, plecanatide in Irritable Bowel Syndrome (IBS-C).
Read NowInsights - Illumina (ILMN) yet again posted great quarterly numbers, surpassing consensus on revenue and earnings.
Read Now
